Antibody Therapeutics for Life

Notices

PharmAbcine, 20th EDQM MAB Working Party
  • Written by PharmAbcine
  • Written date 2019-10-17 09:09:36
  • Inquire 131

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and CEO of PharmAbcine and Expert of EDQM MAB Working Party (https://www.edqm.eu/en/groups-experts-and-working-parties) is participating the 20th EDQM MAB Working Party meeting on October 16-17, 2019.

List





Prev 2019 China BioMed Innovation and Investment Conference
Next PharmAbcine, AUSBIOTECH 2019